These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

549 related items for PubMed ID: 8501148

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combined oestrogen-progestin treatment of vaginal haemorrhage following gonadotrophin-releasing hormone agonist therapy of uterine myomas.
    Friedman AJ.
    Hum Reprod; 1993 Apr; 8(4):540-2. PubMed ID: 8501181
    [Abstract] [Full Text] [Related]

  • 9. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
    Palomba S, Orio F, Russo T, Falbo A, Cascella T, Doldo P, Nappi C, Lombardi G, Mastrantonio P, Zullo F.
    Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
    [Abstract] [Full Text] [Related]

  • 10. Treatment of leiomyomata uteri with short-term leuprolide followed by leuprolide plus estrogen-progestin hormone replacement therapy for 2 years: a pilot study.
    Friedman AJ.
    Fertil Steril; 1989 Mar; 51(3):526-8. PubMed ID: 2537769
    [Abstract] [Full Text] [Related]

  • 11. A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata.
    Palomba S, Affinito P, Tommaselli GA, Nappi C.
    Fertil Steril; 1998 Jul; 70(1):111-8. PubMed ID: 9660431
    [Abstract] [Full Text] [Related]

  • 12. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group.
    Friedman AJ, Hoffman DI, Comite F, Browneller RW, Miller JD.
    Obstet Gynecol; 1991 May; 77(5):720-5. PubMed ID: 1901638
    [Abstract] [Full Text] [Related]

  • 13. Gonadotropin-releasing hormone agonist plus "add-back" hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial.
    Franke HR, van de Weijer PH, Pennings TM, van der Mooren MJ.
    Fertil Steril; 2000 Sep; 74(3):534-9. PubMed ID: 10973651
    [Abstract] [Full Text] [Related]

  • 14. Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for endometriosis-related pelvic pain.
    Friedman AJ, Hornstein MD.
    Fertil Steril; 1993 Aug; 60(2):236-41. PubMed ID: 8339817
    [Abstract] [Full Text] [Related]

  • 15. Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back Therapy.
    Soliman AM, Bonafede M, Farr AM, Castelli-Haley J, Winkel C.
    J Manag Care Spec Pharm; 2016 May; 22(5):573-87. PubMed ID: 27123918
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women.
    Watanabe Y, Nakamura G, Matsuguchi H, Nozaki M, Sano M, Nakano H.
    Fertil Steril; 1992 Jul; 58(1):66-71. PubMed ID: 1624025
    [Abstract] [Full Text] [Related]

  • 17. Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome.
    Mezrow G, Shoupe D, Spicer D, Lobo R, Leung B, Pike M.
    Fertil Steril; 1994 Nov; 62(5):932-7. PubMed ID: 7926137
    [Abstract] [Full Text] [Related]

  • 18. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist.
    Friedman AJ, Barbieri RL, Benacerraf BR, Schiff I.
    Fertil Steril; 1987 Oct; 48(4):560-4. PubMed ID: 3115833
    [Abstract] [Full Text] [Related]

  • 19. Steroidal and nonsteroidal "add-back" therapy: extending safety and efficacy of gonadotropin-releasing hormone agonists in the gynecologic patient.
    Surrey ES.
    Fertil Steril; 1995 Oct; 64(4):673-85. PubMed ID: 7672133
    [Abstract] [Full Text] [Related]

  • 20. The medical management of abnormal uterine bleeding in reproductive-aged women.
    Bradley LD, Gueye NA.
    Am J Obstet Gynecol; 2016 Jan; 214(1):31-44. PubMed ID: 26254516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.